NYSEAMERICAN:NSPR - InspireMD Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.21 -0.06 (-1.41 %)
(As of 04/25/2019 04:00 PM ET)
Previous Close$4.27
Today's Range$4.14 - $4.33
52-Week Range$4.01 - $82.00
Volume69,700 shs
Average Volume84,753 shs
Market Capitalization$5.72 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.

Receive NSPR News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:NSPR
Previous SymbolNASDAQ:NSPR
CUSIPN/A
Phone+1-857-4536553

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees43
Market Cap$5.72 million
Next Earnings Date5/6/2019 (Estimated)
OptionableNot Optionable

InspireMD (NYSEAMERICAN:NSPR) Frequently Asked Questions

What is InspireMD's stock symbol?

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

When did InspireMD's stock split? How did InspireMD's stock split work?

InspireMD shares reverse split on Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split.

How were InspireMD's earnings last quarter?

InspireMD Inc (NYSEAMERICAN:NSPR) announced its earnings results on Tuesday, February, 19th. The medical equipment provider reported ($2.50) earnings per share for the quarter. The medical equipment provider earned $0.82 million during the quarter. View InspireMD's Earnings History.

When is InspireMD's next earnings date?

InspireMD is scheduled to release their next quarterly earnings announcement on Monday, May 6th 2019. View Earnings Estimates for InspireMD.

What is the consensus analysts' recommendation for InspireMD?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for InspireMD.

Has InspireMD been receiving favorable news coverage?

News stories about NSPR stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. InspireMD earned a media sentiment score of 1.5 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days.

Are investors shorting InspireMD?

InspireMD saw a decrease in short interest in April. As of April 15th, there was short interest totalling 81,391 shares, a decrease of 86.1% from the March 29th total of 585,759 shares. Based on an average daily volume of 362,907 shares, the days-to-cover ratio is presently 0.2 days. Approximately 11.0% of the company's shares are sold short. View InspireMD's Current Options Chain.

Who are some of InspireMD's key competitors?

What other stocks do shareholders of InspireMD own?

Who are InspireMD's key executives?

InspireMD's management team includes the folowing people:
  • Dr. James J. Barry, Pres, CEO & Director (Age 60)
  • Mr. Craig Shore, CFO, Chief Admin. Officer, Sec. & Treasurer (Age 58)
  • Mr. Agustin V. Gago, Exec. VP & Chief Commercial Officer (Age 59)
  • Mr. Roei Samuri, VP of Operations
  • Dr. Sol J. Barer, Special Advisor to the Board (Age 72)

How do I buy shares of InspireMD?

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is InspireMD's stock price today?

One share of NSPR stock can currently be purchased for approximately $4.21.

How big of a company is InspireMD?

InspireMD has a market capitalization of $5.72 million. InspireMD employs 43 workers across the globe.

What is InspireMD's official website?

The official website for InspireMD is http://www.inspiremd.com/.

How can I contact InspireMD?

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.


MarketBeat Community Rating for InspireMD (NYSEAMERICAN NSPR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  140 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  272
MarketBeat's community ratings are surveys of what our community members think about InspireMD and other stocks. Vote "Outperform" if you believe NSPR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel